These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
293 related articles for article (PubMed ID: 16691072)
21. Sex differences in the clinical, immunological and virological parameters of HIV-infected patients treated with HAART. Collazos J; Asensi V; Cartón JA AIDS; 2007 Apr; 21(7):835-43. PubMed ID: 17415038 [TBL] [Abstract][Full Text] [Related]
22. Structured treatment interruptions--new findings. Benson CA Top HIV Med; 2006; 14(3):107-11. PubMed ID: 16946455 [TBL] [Abstract][Full Text] [Related]
23. Influence of repeated cycles of structured therapy interruption on the rate of recovery of CD4+ T cells after highly active antiretroviral therapy resumption. León A; Martinez E; Milinkovic A; Mora B; Mallolas J; Blanco JL; Larrousse M; Laguno M; Gallart T; Plana M; Gatell JM; Garcia F J Antimicrob Chemother; 2009 Jan; 63(1):184-8. PubMed ID: 19001447 [TBL] [Abstract][Full Text] [Related]
24. CD4+ lymphocyte count and plasma HIV RNA levels in a survey of 1602 HIV-infected patients in Bordeaux, France, 1996-1997. Groupe d'Epidemiologie Clinique da SIDA en Aquitaine. Marimoutou C; Chêne G; Pellegrin I; Moreau JF; Spira R; Neau D; Lacoste D; Ceccaldi J; Malvy D; Dabis F AIDS; 1998 May; 12(8):962-4. PubMed ID: 9631157 [No Abstract] [Full Text] [Related]
25. Mutation and control of the human immunodeficiency virus. Stengel RF Math Biosci; 2008 Jun; 213(2):93-102. PubMed ID: 18439629 [TBL] [Abstract][Full Text] [Related]
26. CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy. Khanna N; Opravil M; Furrer H; Cavassini M; Vernazza P; Bernasconi E; Weber R; Hirschel B; Battegay M; Kaufmann GR; Clin Infect Dis; 2008 Oct; 47(8):1093-101. PubMed ID: 18783328 [TBL] [Abstract][Full Text] [Related]
27. Predictive factors for immunological and virological endpoints in Thai patients receiving combination antiretroviral treatment. Srasuebkul P; Ungsedhapand C; Ruxrungtham K; Boyd MA; Phanuphak P; Cooper DA; Law MG HIV Med; 2007 Jan; 8(1):46-54. PubMed ID: 17305932 [TBL] [Abstract][Full Text] [Related]
28. HIV treatment interruptions: a review. Newcomb-Fernandez J Res Initiat Treat Action; 2003; 9(2):5-13. PubMed ID: 14989199 [No Abstract] [Full Text] [Related]
30. HIV neutralizing antibody titer during structured treatment interruption of highly active antiretroviral therapy. Nicastri E; Dori L; Buonomini AR; Tommasi C; De Nardo P; Bellagamba R; Corpolongo A; Montano M; Sordillo P; Volpi A; Sarmati L; Andreoni M AIDS; 2012 Jul; 26(11):1451-2. PubMed ID: 22767346 [No Abstract] [Full Text] [Related]
31. Stopping antiretroviral therapy. Taylor S; Boffito M; Khoo S; Smit E; Back D AIDS; 2007 Aug; 21(13):1673-82. PubMed ID: 17690564 [No Abstract] [Full Text] [Related]
32. Diagnostic accuracy of CD4 cell count increase for virologic response after initiating highly active antiretroviral therapy. Bisson GP; Gross R; Strom JB; Rollins C; Bellamy S; Weinstein R; Friedman H; Dickinson D; Frank I; Strom BL; Gaolathe T; Ndwapi N AIDS; 2006 Aug; 20(12):1613-9. PubMed ID: 16868442 [TBL] [Abstract][Full Text] [Related]
33. Antiretroviral rounds. First holiday was a disaster: should she take another? Estanislao L; Simpson D; Cohen CJ AIDS Clin Care; 2004 May; 16(5):40-1. PubMed ID: 15199864 [No Abstract] [Full Text] [Related]
34. Efficacy of highly active antiretroviral therapy in HIV-1 infected children in Kenya. Song R; Jelagat J; Dzombo D; Mwalimu M; Mandaliya K; Shikely K; Essajee S Pediatrics; 2007 Oct; 120(4):e856-61. PubMed ID: 17846147 [TBL] [Abstract][Full Text] [Related]
35. Dynamics of HIV viral load in blood and semen of patients under HAART: impact of therapy in assisted reproduction procedures. La Sala GB; Pilotti E; Nicoli A; Pinelli S; Villani MT; Ronzi P; Zendri E; Re MC; Magnani G; Casoli C AIDS; 2007 Jan; 21(3):377-9. PubMed ID: 17255749 [TBL] [Abstract][Full Text] [Related]
37. Predictors of virological outcome and safety in primary HIV type 1-infected patients initiating quadruple antiretroviral therapy: QUEST GW PROB3005. Hoen B; Cooper DA; Lampe FC; Perrin L; Clumeck N; Phillips AN; Goh LE; Lindback S; Sereni D; Gazzard B; Montaner J; Stellbrink HJ; Lazzarin A; Ponscarme D; Staszewski S; Mathiesen L; Smith D; Finlayson R; Weber R; Wegmann L; Janossy G; Kinloch-de Loes S; Clin Infect Dis; 2007 Aug; 45(3):381-90. PubMed ID: 17599319 [TBL] [Abstract][Full Text] [Related]
38. Effect of tenofovir subtraction on HIV plasma viraemia, CD4+ T-cell count and resistance in a patient with baseline K65R and M184V mutations. Hsu R; Lanier ER; Rouse EG; Oie KL; Pappa KA; Ross LL Antivir Ther; 2008; 13(5):735-7. PubMed ID: 18771059 [TBL] [Abstract][Full Text] [Related]
39. Immunophenotype of HIV+ patients during CD4 cell-monitored treatment interruption: role of the IL-7/IL-7 receptor system. Nemes E; Lugli E; Nasi M; Ferraresi R; Pinti M; Bugarini R; Borghi V; Prati F; Esposito R; Cossarizza A; Mussini C AIDS; 2006 Oct; 20(16):2021-32. PubMed ID: 17053348 [TBL] [Abstract][Full Text] [Related]
40. Beware of drug holidays before HIV salvage therapy. Hirschel B N Engl J Med; 2003 Aug; 349(9):827-8. PubMed ID: 12944566 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]